Viewing Study NCT04796012


Ignite Creation Date: 2025-12-26 @ 11:13 PM
Ignite Modification Date: 2026-03-17 @ 10:12 PM
Study NCT ID: NCT04796012
Status: RECRUITING
Last Update Posted: 2025-12-24
First Post: 2021-02-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: VITAS: Atezolizumab in Combination With Chemotherapy for Pediatric Relapsed/Refractory Solid Tumors
Sponsor: University of Texas Southwestern Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Solid Tumor View
None Rhabdomyosarcoma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Relapsed solid tumor View
None Refractory solid tumor View
None Rhabdomyosarcoma View